Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.65
-0.18 (-6.36%)
At close: Aug 19, 2025, 3:06 PM

Ventyx Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-135.12M -192.96M -108.43M -83.75M
Depreciation & Amortization
1.35M 941K 470K 30K
Stock-Based Compensation
22.93M 28.59M 16.57M 2.73M
Other Working Capital
-7.92M 6.55M -6.77M 1.57M
Other Non-Cash Items
-9.47M -8.89M -2.23M 38.32M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-10.56M 5.81M -5.16M 4.02M
Operating Cash Flow
-130.87M -166.52M -98.77M -38.65M
Capital Expenditures
-241K -514K -275K -262K
Cash Acquisitions
n/a n/a 74.66K 1.9M
Purchase of Investments
-283.65M -272.27M -347.24M -232.5M
Sales Maturities Of Investments
268.38M 373.73M 272.58M 16.5M
Other Investing Acitivies
n/a n/a -74.66K n/a
Investing Cash Flow
-15.51M 100.94M -74.93M -214.37M
Debt Repayment
n/a n/a n/a 450K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
466K 4.92M 2.37M 65K
Financial Cash Flow
122.11M 53.33M 167.77M 323.55M
Net Cash Flow
-24.32M -12.27M -5.97M 70.55M
Free Cash Flow
-131.11M -167.04M -99.05M -38.91M